Published in Biomarkers on August 28, 2003
Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803. Cancer (2010) 1.14
Gene-environment interaction in tobacco-related cancers. Carcinogenesis (2008) 1.12
Cigarette smoking, genetic polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study. BMC Cancer (2010) 1.03
Case-only study of interactions between metabolic enzymes and smoking in colorectal cancer. BMC Cancer (2007) 0.95
Glutathione S-transferase (GST) gene polymorphisms, cigarette smoking and colorectal cancer risk among Chinese in Singapore. Carcinogenesis (2011) 0.93
GSTM1, GSTT1 and GSTP1 polymorphisms in the Korean population. J Korean Med Sci (2005) 0.86
Genetic association studies in cancer: good, bad or no longer ugly? Hum Genomics (2006) 0.75
A comparison of approaches for association studies of polymorphisms and colorectal cancer risk. Colorectal Dis (2012) 0.75
The impact of heat waves and cold spells on mortality rates in the Dutch population. Environ Health Perspect (2001) 3.89
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
Sunshine is good medicine. The health benefits of ultraviolet-B induced vitamin D production. J Cosmet Dermatol (2003) 3.33
Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology (2000) 3.01
Effect of the age at which smoking begins on frequency of smoking in adulthood. N Engl J Med (1991) 2.96
Nonpalpable breast lesions: correlation of stereotaxic large-core needle biopsy and surgical biopsy results. Radiology (1993) 2.58
Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene. J Invest Dermatol (1998) 2.37
High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med (1998) 2.30
Ethnic differences in estrogen metabolism in healthy women. J Natl Cancer Inst (1996) 2.29
Basal cell carcinoma. BMJ (2003) 2.10
Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol (2006) 2.02
Initial metabolic and hormonal response to acute myocardial infarction. Lancet (1974) 2.02
The human glutathione S-transferases: studies on the tissue distribution and genetic variation of the GST1, GST2 and GST3 isozymes. Ann Hum Genet (1984) 1.85
Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arthritis. Ann Rheum Dis (2009) 1.78
Re: Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst (1994) 1.74
Identification of two lithocholic acid-binding proteins. Separation of ligandin from glutathione S-transferase B. Biochem J (1979) 1.71
Feasibility of a large prospective study in general practice: an Italian experience. Gruppo di Studio sulla Pressione Arteriosa nell'Anziano. Br Med J (Clin Res Ed) (1987) 1.65
Polymorphism at the glutathione S-transferase GSTP1 locus. A new marker for bronchial hyperresponsiveness and asthma. Am J Respir Crit Care Med (2000) 1.61
Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. Free Radic Res (1995) 1.56
Homocysteine, vitamin B12, and serum and erythrocyte folate in peritoneal dialysis and hemodialysis patients. Perit Dial Int (2000) 1.48
Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood (1998) 1.47
Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol (2001) 1.47
Risk factors for deep venous thrombosis of the upper extremities. Ann Intern Med (1997) 1.45
Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer. Lancet (2001) 1.42
No association between genetic hemochromatosis and alpha1-antitrypsin deficiency. Hepatology (1996) 1.42
Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology (2001) 1.40
Lipid profile during rhGH therapy in pediatric renal transplant patients. Pediatr Transplant (2002) 1.40
Functional significance of different human CYP1A1 genotypes. Carcinogenesis (1994) 1.40
Cultures of exfoliated epithelial cells from different locations of the human urinary tract and the renal tubular system. Arch Toxicol (2000) 1.31
The development of glutathione S-transferase and glutathione peroxidase activities in human lung. Biochim Biophys Acta (1986) 1.30
Glutathione S-transferase polymorphisms in MS: their relationship to disability. Neurology (2000) 1.30
GSTM1 null polymorphism at the glutathione S-transferase M1 locus: phenotype and genotype studies in patients with primary biliary cirrhosis. Gut (1993) 1.30
A study of the structures of the YaYa and YaYc glutathione S-transferases from rat liver cytosol. Evidence that the Ya monomer is responsible for lithocholate-binding activity. Biochem J (1981) 1.29
Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis (1996) 1.28
Metabolic polymorphisms and cancer susceptibility. Cancer Surv (1995) 1.26
Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med (2000) 1.26
Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res (1995) 1.25
Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics (1998) 1.25
Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: improved reliability with 14-gauge, directional, vacuum-assisted biopsy. Radiology (1997) 1.24
Cholic acid binding by glutathione S-transferases from rat liver cytosol. Biochem J (1980) 1.24
The human glutathione S-transferases: developmental aspects of the GST1, GST2, and GST3 loci. Biochem Genet (1985) 1.23
Equilibrium-dialysis studies of the interaction between cholic acid and 100000g-supernatant preparations from the rat liver. Biochem J (1976) 1.22
Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease. Hepatology (2001) 1.21
Basal cell carcinoma. J R Soc Med (1998) 1.20
Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours. Lancet (1994) 1.20
Polymorphisms at the glutathione S-transferase, GSTP1 locus: a novel mechanism for susceptibility and development of atopic airway inflammation. Allergy (2000) 1.19
Risk of cerebral vein thrombosis and oral contraceptives. Lancet (1998) 1.18
Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res (2000) 1.18
Binding of bile acids by 100 000g supernatants from rat liver. Biochem J (1977) 1.16
Partial purification of two lithocholic acid-binding proteins from rat liver 100 000g supernatants. Biochem J (1977) 1.16
Diet, metabolic polymorphisms and dna adducts: the EPIC-Italy cross-sectional study. Int J Cancer (2000) 1.16
Influence of CYP2C9 polymorphisms, demographic factors and concomitant drug therapy on warfarin metabolism and maintenance dose. Pharmacogenomics J (2005) 1.15
Phenol sulphotransferase SULT1A1 polymorphism: molecular diagnosis and allele frequencies in Caucasian and African populations. Biochem J (1999) 1.15
Studies of the development of basic, neutral and acidic isoenzymes of glutathione S-transferase in human liver, adrenal, kidney and spleen. Biochem J (1987) 1.14
Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol Biomarkers Prev (2001) 1.14
11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours. Br J Cancer (2006) 1.14
Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis. Arterioscler Thromb Vasc Biol (1999) 1.12
Use of site-directed mutagenesis of allele-specific PCR primers to identify the GSTM1 A, GSTM1 B, GSTM1 A,B and GSTM1 null polymorphisms at the glutathione S-transferase, GSTM1 locus. Biochem J (1993) 1.08
The human glutathione S-transferases. Immunohistochemical studies of the developmental expression of Alpha- and Pi-class isoenzymes in liver. Biochem J (1988) 1.07
Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Res (1996) 1.06
Genetic polymorphisms of glutathione S-transferases and disease activity of rheumatoid arthritis. Clin Exp Rheumatol (2009) 1.06
Influence of polymorphisms of GSTM1 and GSTT1 for risk of renal cell cancer in workers with long-term high occupational exposure to trichloroethene. Arch Toxicol (1997) 1.06
Risk factors for basal cell carcinoma in the UK: case-control study in 806 patients. J R Soc Med (1997) 1.06
Effects of glutathione S-transferase M1, T1 and P1 on lung function in asthmatic families. Clin Exp Allergy (2005) 1.06
Death from cardiovascular disease in Italy, 1972-1981: decline in mortality rates and possible causes. Int J Epidemiol (1988) 1.06
Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up. Arterioscler Thromb Vasc Biol (1998) 1.06
Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci. Carcinogenesis (1999) 1.06
Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin. Br J Cancer (1999) 1.05
Multiple cutaneous basal cell carcinomas: glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrual. Carcinogenesis (1996) 1.03
Identification of polymorphism at the glutathione S-transferase, GSTM3 locus: evidence for linkage with GSTM1*A. Biochem J (1995) 1.02
Magnesium intake and colorectal cancer risk in the Netherlands Cohort Study. Br J Cancer (2007) 1.02
Distinct distribution of HPV types among cancer-free Afro-Caribbean women from Tobago. Biomarkers (2007) 1.01
Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch Toxicol (2000) 1.01
Association of polymorphism in glutathione S-transferase loci with susceptibility and outcome in rheumatoid arthritis: comparison with the shared epitope. Ann Rheum Dis (1999) 1.01
Relationship between genotype and function of the human CYP1A1 gene. J Toxicol Environ Health (1993) 1.01
Association of protein kinase C alpha (PRKCA) gene with multiple sclerosis in a UK population. Brain (2004) 1.00
Recognition of oxidized DNA bases by sera of patients with inflammatory diseases. Free Radic Biol Med (1993) 1.00
The glyceryl [14C]tripalmitate breath test: a reassessment. Clin Chim Acta (1980) 1.00
The glutathione S-transferases: polymerase chain reaction studies on the frequency of the GSTM1 0 genotype in patients with pituitary adenomas. Carcinogenesis (1993) 1.00
Risk indicators for out-of-hospital cardiac arrest in patients with coronary artery disease. J Clin Epidemiol (1999) 1.00
The sources of plasma cyclic AMP: studies in the rat using isoprenaline, nicotinic acid and glucagon. Eur J Clin Invest (1975) 1.00
Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity. J Neuroimmunol (2002) 1.00
MTHFR C677T polymorphism, GSTM1 deletion and male infertility: a possible suggestion of a gene-gene interaction? Biomarkers (2006) 0.99
Multiple basal cell carcinomas and malignant melanoma following radiotherapy for ankylosing spondylitis. Clin Exp Dermatol (2000) 0.99
Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years. Int J Epidemiol (2003) 0.99
Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis. Blood (2001) 0.98
Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck. Am J Pathol (2001) 0.98
Reversible ageusia as an effect of clopidogrel treatment. Lancet (2000) 0.98
Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res (1998) 0.97